Le-Blen Vitamin C Serum

Manufacturer
LeBlen Beauty Inc | LeBlen Beauty Inc. | Cosmetic Lab Inc.
Effective date
2018-04-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:55:18

Label at a glance#

ProductLe-Blen Vitamin C Serum
Active ingredientMAGNESIUM ASCORBYL PHOSPHATE, HYALURONATE SODIUM
Label structure8 sections

Indications and uses

Helps to brighten and make even toned skin

Dosage and administration

Apply 2 or 3 drops after cleansing. Massage gently until it is absorbed.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

SODIUM HYALURONATE (5.0%) ------------------------------------------------------------------ Skin protectant

MAGNESIUM ASCORBYL PHOSPHATE (1.0%) ---------------------------------------------- Skin protectant

Purposes

OTC - PURPOSE SECTION

Skin Protectant

Uses

INDICATIONS & USAGE SECTION

Helps to brighten and make even toned skin

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply 2 or 3 drops after cleansing. Massage gently until it is absorbed.

Warnings

WARNINGS SECTION

For external use only

Do not use when skin is red, inflamed, irritated, or painful

When using this product

do not apply on other parts of the body

do not use on damaged or broken skin

avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water

do not apply directly to wound or open cut

Stop use and ask a doctor if

Rash or irritation on skin develops and lasts

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water(Aqua), Glycerin, Xanthan Gum, Phenoxyethanol, Polysorbate 20, Ethylhexylglycerin, Saccharomyces Lysate Extract, Glucosamine HCL, Niacinamide, Algae Extract, Citrus Aurntium Dulcis (Orange) Peel Oil

Le-Blen Vitamin C Serum

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Le Blen Vitamin C SerumLe Blen Vitamin C Serum

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72271-103-012020-01-31C16284748780-19d75b9d0-d528-f424-e053-dadaa90a57ceLe-Blen Vitamin C Serum

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72271-103-01Le-Blen Vitamin C Serum56.7 g in 1 BOTTLE, DROPPERLOTION56.71

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72271-103LE-BLEN VITAMIN C SERUM (SODIUM HYALURONATE, MAGNESIUM ASCORBYL PHOSPHATE) LOTION [LEBLEN BEAUTY INC]1Legacy NDC, 1 package rows20180430_6b15bb5e-b8f1-2de3-e053-2991aa0ad616.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72271-10372271-103-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
6b160715-8c09-37e7-e053-2a91aa0a29006b15bb5e-b8f1-2de3-e053-2991aa0ad6162018-04-30WarningsExact identifier
spl id: 6b160715-8c09-37e7-e053-2a91aa0a2900
spl set id: 6b15bb5e-b8f1-2de3-e053-2991aa0ad616

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.